Author

Keziban Ünsal-Kaçmaz

Bristol-Myers Squibb (United States)ORCID 0009-0001-0120-2099Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Adam M. FarkasiD· 1 shared Amir HorowitziD· 1 shared Austin HakeiD· 1 shared Eric E. SchadtiD· 1 shared Güray AktürkiD· 1 shared John P. SfakianosiD· 1 shared Jun ZhuiD· 1 shared Kristin G. BeaumontiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adam M. FarkasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsClinical Cancer ResearchPeer-reviewedApr 9, 2021

Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing

Li Wang, John P. Sfakianos, Kristin G. Beaumont…·Matthew D. Galsky

The paper identifies proinflammatory monocytes/macrophages associated with resistance to PD-1/PD-L1 blockade in urothelial cancer using bulk and single-cell RNA sequencing.

97 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky